# A Research Study Investigating Mim8 in People With Haemophilia A

> **NCT04204408** · PHASE2 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 275 (actual)

## Conditions studied

- Healthy Volunteers
- Haemophilia A With or Without Inhibitors

## Interventions

- **DRUG:** NNC0365-3769 (Mim8)
- **DRUG:** Placebo (Mim8)

## Key facts

- **NCT ID:** NCT04204408
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-10
- **Primary completion:** 2023-10-06
- **Final completion:** 2023-10-06
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04204408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04204408, "A Research Study Investigating Mim8 in People With Haemophilia A". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04204408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*